ENTRY       K12348                      KO
NAME        ASAH1
DEFINITION  acid ceramidase [EC:3.5.1.23]
PATHWAY     ko00600  Sphingolipid metabolism
            ko04142  Lysosome
MODULE      M00099  Sphingosine biosynthesis
DISEASE     H00138  Farber lipogranulomatosis
            H00424  Defects in the degradation of sphingomyelin
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Metabolism
              Lipid metabolism
               00600 Sphingolipid metabolism
                K12348  ASAH1; acid ceramidase
             Cellular Processes
              Transport and catabolism
               04142 Lysosome
                K12348  ASAH1; acid ceramidase
            KEGG modules [BR:ko00002]
             Pathway module
              Carbohydrate and lipid metabolism
               Lipid metabolism
                M00099  Sphingosine biosynthesis
                 K12348  ASAH1; acid ceramidase
            Enzymes [BR:ko01000]
             3. Hydrolases
              3.5  Acting on carbon-nitrogen bonds, other than peptide bonds
               3.5.1  In linear amides
                3.5.1.23  ceramidase
                 K12348  ASAH1; acid ceramidase
            Peptidases [BR:ko01002]
             Cysteine Peptidases
              Family C89
               K12348  ASAH1; acid ceramidase
            Exosome [BR:ko04147]
             Exosomal proteins
              Exosomal proteins of other body fluids (saliva and urine)
               K12348  ASAH1; acid ceramidase
DBLINKS     RN: R01494
            GO: 0017040
GENES       HSA: 427(ASAH1)
            PTR: 464022(ASAH1)
            PPS: 100991999(ASAH1)
            GGO: 101149522(ASAH1)
            PON: 100171626(ASAH1)
            MCC: 703699(ASAH1)
            MCF: 102118393(ASAH1)
            MMU: 11886(Asah1)
            RNO: 84431(Asah1)
            CGE: 100771068(Asah1)
            HGL: 101724913(Asah1)
            TUP: 102490603(ASAH1)
            CFA: 482897(ASAH1)
            AML: 100471625
            FCA: 101082231(ASAH1)
            PTG: 102969154(ASAH1)
            BTA: 510620(ASAH1)
            BOM: 102285015(ASAH1)
            PHD: 102326915(ASAH1)
            CHX: 102169733(ASAH1)
            SSC: 100512932
            CFR: 102503963(ASAH1)
            BACU: 103004383(ASAH1)
            LVE: 103084758(ASAH1)
            ECB: 100054433(ASAH1)
            MYB: 102261355(ASAH1)
            MYD: 102772524(ASAH1)
            PALE: 102884758(ASAH1)
            MDO: 100021204(ASAH1)
            SHR: 100927628(ASAH1)
            OAA: 100093499(ASAH1)
            GGA: 422727(ASAH1)
            MGP: 100550236
            TGU: 100223185(ASAH1)
            FAB: 101806040(ASAH1)
            PHI: 102108790(ASAH1)
            APLA: 101801719(ASAH1)
            FPG: 101917300(ASAH1)
            FCH: 102045851(ASAH1)
            CLV: 102098583(ASAH1)
            ASN: 102383990(ASAH1)
            AMJ: 102566045(ASAH1)
            PSS: 102444687
            CMY: 102930137(ASAH1)
            ACS: 100565312
            PBI: 103052913(ASAH1)
            XLA: 447327(asah1)
            XTR: 100485700(asah1)
            DRE: 393549(asah1b) 450068(asah1a)
            TRU: 101065149(ASAH)
            MZE: 101476420
            OLA: 101161703
            XMA: 102231620
            LCM: 102355600(ASAH1)
            CMK: 103178195(asah1)
            BFO: BRAFLDRAFT_117224
            CIN: 100179893
            SPU: 579635 593569
            ISC: IscW_ISCW010877
            CEL: CELE_K11D2.2(asah-1)
            CBR: CBG00863 CBG15381(Cbr-asah-1)
            TSP: Tsp_09460
            NVE: NEMVE_v1g246414
            HMG: 100206178
            TAD: TRIADDRAFT_64237
            MIS: MICPUN_83138
            MBR: MONBRDRAFT_10877
            DFA: DFA_06303
            NGR: NAEGRDRAFT_72944
REFERENCE   PMID:8955159
  AUTHORS   Koch J, Gartner S, Li CM, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman EH, Sandhoff K
  TITLE     Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease.
  JOURNAL   J Biol Chem 271:33110-5 (1996)
///
